This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in the Cards for Universal Health's (UHS) Q2 Earnings?
by Zacks Equity Research
Universal Health's (UHS) second-quarter results are likely to reflect improving revenues stemming from growing patient admissions, partly offset by high costs.
Encompass Health (EHC) Continues to Boost Presence in Florida
by Zacks Equity Research
Encompass Health (EHC) plans to construct an inpatient rehabilitation hospital in Florida in a bid to offer improved health outcomes across the state.
Encompass Health (EHC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EHC or AMED: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. AMED: Which Stock Is the Better Value Option?
Encompass Health (EHC) to Expand Inpatient Rehabilitation Unit
by Zacks Equity Research
Encompass Health (EHC) to construct an inpatient rehabilitation hospital to capture a market with great prospects.
HCA Healthcare (HCA) Buys 80% Stake in BHS, Boosts Network
by Zacks Equity Research
HCA Healthcare (HCA) completes purchase of majority stake in Brookdale's BHS, which has added around 80 care sites to the former's portfolio enabling it to offer enhanced healthcare services.
Encompass Health (EHC), Altru Forms JV to Serve North Dakota
by Zacks Equity Research
Encompass Health (EHC) inks JV with Altru for sharing responsibility of operating the latter's inpatient rehabilitation hospital and offer better health outcomes across North Dakota.
Forget Clover Health (COLV), Buy 3 Non-Meme Healthcare Bets Instead
by Sapna Bagaria
Despite being hotly traded on social-media platforms, Cover Health (CLOV) offers little investment value to long-term investors.
Here's Why You Should Retain Stryker (SYK) Stock Right Now
by Zacks Equity Research
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises a concern.
NextGen (NXGN) Partners With Palmetto to Boost Patient Experience
by Zacks Equity Research
NextGen (NXGN) collaborates with Palmetto to enhance patient experience, through the latter's adoption of NextGen RCM Services.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Banking on its Acute Care and Behavioral Health platforms along with a robust capital position, Universal Health (UHS) holds potential to reap benefits for investors.
Here's Why You Should Retain Integer Holdings (ITGR) Stock
by Zacks Equity Research
Integer Holdings (ITGR) continues to gain traction from portfolio management.
The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita
5 Reasons That Make Encompass Health (EHC) an Attractive Bet
by Zacks Equity Research
Encompass Health's (EHC) optimistic business prospects make it a lucrative stock to own for strong gains.
Save Your Portfolio From Inflation With Four Healthcare Stocks
by Zacks Equity Research
Healthcare stocks with long-term growth visibility can be important additions to investment portfolio when inflation runs high.
Avantor, Inc. (AVTR) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why You Should Retain Change Healthcare (CHNG) Stock
by Zacks Equity Research
Change Healthcare (CHNG) continues to benefit from robust payment accuracy business. However, intense competition remains a woe.
Patterson Companies' (PDCO) Unit Completes Miller Vet Buyout
by Zacks Equity Research
Patterson Companies' (PDCO) subsidiary completes acquisition of Miller Vet, which is likely to bolster its Animal Health's presence in the companion animal market.
Encompass Health (EHC) Expands Inpatient Rehab Business
by Zacks Equity Research
Encompass Health (EHC) continues to strengthen its inpatient rehabilitation business by opening a hospital.
Ecolab (ECL) to Aid Life Sciences Industry With New Offering
by Zacks Equity Research
Ecolab (ECL) unveils new virtual service offering to help the life sciences industry to address cleaning and disinfection challenges.
Here's Why You Should Invest in Intuitive Surgical (ISRG) Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System.
DaVita's (DVA) Deal to Aid Patients in Kidney Transplantation
by Zacks Equity Research
DaVita (DVA) and NKF collaborate to help kidney patients seeking a living donor, thereby improving health equity in kidney transplant process.
Cardinal Health's (CAH) Arm Receives FDA Nod for LYMPHOSEEK
by Zacks Equity Research
Cardinal Health's (CAH) Nuclear & Precision Health Solutions receive FDA approval for LYMPHOSEEK injection.
BD's (BDX) Milestone Pandemic Orders to Support Vaccinations
by Zacks Equity Research
BD (BDX) receives 2 billion pandemic orders for needles and syringes to support global COVID-19 vaccination efforts.
Here's Why You Should Retain AmerisourceBergen (ABC) Now
by Zacks Equity Research
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment.